380 related articles for article (PubMed ID: 17383573)
41. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ
J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269
[TBL] [Abstract][Full Text] [Related]
42. In vivo imaging of the brain vesicular monoamine transporter.
Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
[TBL] [Abstract][Full Text] [Related]
43. In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.
Sossi V; Holden JE; Topping GJ; Camborde ML; Kornelsen RA; McCormick SE; Greene J; Studenov AR; Ruth TJ; Doudet DJ
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1407-15. PubMed ID: 17245418
[TBL] [Abstract][Full Text] [Related]
44. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
Okamura N; Villemagne VL; Drago J; Pejoska S; Dhamija RK; Mulligan RS; Ellis JR; Ackermann U; O'Keefe G; Jones G; Kung HF; Pontecorvo MJ; Skovronsky D; Rowe CC
J Nucl Med; 2010 Feb; 51(2):223-8. PubMed ID: 20080893
[TBL] [Abstract][Full Text] [Related]
45. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
Bohnen NI; Albin RL; Koeppe RA; Wernette KA; Kilbourn MR; Minoshima S; Frey KA
J Cereb Blood Flow Metab; 2006 Sep; 26(9):1198-212. PubMed ID: 16421508
[TBL] [Abstract][Full Text] [Related]
46. Quantitative study of
Jung Lung H; Weng YH; Wen MC; Hsiao IT; Lin KJ
Sci Rep; 2018 Oct; 8(1):16027. PubMed ID: 30375444
[TBL] [Abstract][Full Text] [Related]
47. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.
Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE
Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678
[TBL] [Abstract][Full Text] [Related]
48. Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers.
Kilbourn MR
Nucl Med Biol; 2010 Nov; 37(8):869-71. PubMed ID: 21055616
[TBL] [Abstract][Full Text] [Related]
49. Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas.
Tsao HH; Skovronsky DM; Lin KJ; Yen TC; Wey SP; Kung MP
Nucl Med Biol; 2011 Oct; 38(7):1029-34. PubMed ID: 21982574
[TBL] [Abstract][Full Text] [Related]
50. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
[TBL] [Abstract][Full Text] [Related]
51. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
Collantes M; Barajas M; Quincoces G; Ramos-Membrive R; Martí-Climent JM; Ecay M; Rodríguez S; Escalada J; Peñuelas I
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):447-455. PubMed ID: 25881691
[TBL] [Abstract][Full Text] [Related]
52. Chronic manganism: A long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan.
Huang CY; Liu CH; Tsao E; Hsieh CJ; Weng YH; Hsiao IT; Yen TC; Lin KJ; Huang CC
J Neurol Sci; 2015; 353(1-2):102-6. PubMed ID: 25936253
[TBL] [Abstract][Full Text] [Related]
53. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
54. Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy.
Ma JH; Dong C; Qiao HW; Barret O; Tamagnan GD; Mao W; Xu EH; Zhang C; Lu J; Chan P; Liu SY
Mov Disord; 2024 May; 39(5):847-854. PubMed ID: 38477228
[TBL] [Abstract][Full Text] [Related]
55. Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.
Narendran R; Jedema HP; Lopresti BJ; Mason NS; Himes ML; Bradberry CW
Biol Psychiatry; 2015 Mar; 77(5):488-92. PubMed ID: 25062684
[TBL] [Abstract][Full Text] [Related]
56. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
57. An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2.
Zhu L; Liu Y; Plössl K; Lieberman B; Liu J; Kung HF
Nucl Med Biol; 2010 Feb; 37(2):133-41. PubMed ID: 20152712
[TBL] [Abstract][Full Text] [Related]
58. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE
J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
[TBL] [Abstract][Full Text] [Related]
59. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE
Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
[TBL] [Abstract][Full Text] [Related]
60. IPT: a novel iodinated ligand for the CNS dopamine transporter.
Kung MP; Essman WD; Frederick D; Meegalla S; Goodman M; Mu M; Lucki I; Kung HF
Synapse; 1995 Aug; 20(4):316-24. PubMed ID: 7482291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
